Ultrasound-activated Cu 4 SnS 4 nanoplatform for dual-pathway amplification of reactive oxygen species and enhanced antibacterial therapy.
文献摘要
Effective eradication of bacterial infections remains significantly restricted by poor drug penetration, persistent biofilms, and insufficient reactive oxygen species (ROS) generation within complex infectious microenvironments. Herein, a multi-metal sulfide semiconductor, Cu 4 SnS 4 (CTS), is engineered as an ultrasound (US)-activatable nanoplatform that integrates chemodynamic therapy (CDT) and sonodynamic therapy (SDT) to achieve spatiotemporally controlled ROS amplification for enhanced antibacterial therapy. In acidic and H 2 O 2 -enriched infection microenvironments, CTS catalyzes a Fenton-like reaction through a dynamic Cu + /Cu 2+ redox cycle, enabling continuous hydroxyl radical (·OH) production. Upon US irradiation, sonogenerated charge-carrier separation accelerates electron transfer and copper valence cycling, further amplifying ·OH generation efficiency. Simultaneously, the narrow-bandgap electronic structure of CTS promotes efficient sonodynamic energy transfer to molecular oxygen, resulting in substantial singlet oxygen ( 1 O 2 ) generation. Coupled with US-induced cavitation effects, the platform establishes a dual-pathway ROS amplification mechanism that markedly enhances bacterial membrane disruption and biofilm eradication. Consequently, CTS exhibits potent broad-spectrum antibacterial activity and admire anti-biofilm efficacy under US activation, enabling efficient bacterial clearance in challenging infection environments. Collectively, this work presents a semiconductor-based, US-responsive antibacterial strategy for programmable ROS amplification and highlights the therapeutic potential of multi-metal sulfide nanoagents for the treatment of deep-seated and drug-resistant bacterial infections. STATEMENT OF SIGNIFICANCE: Antibiotic-resistant infections and biofilm-associated diseases remain difficult to treat because of limited antimicrobial penetration and therapeutic resistance. Here, we report a Cu 4 SnS 4 (CTS) semiconductor nanozyme that overcomes the insufficient reactive oxygen species generation of conventional sonodynamic antibacterial systems by integrating chemodynamic and sonodynamic mechanisms. Ultrasound activation enables enhanced ROS amplification through coordinated catalytic and semiconductor properties, leading to effective bacterial eradication, biofilm disruption, and tissue repair. This work provides a new design strategy for ultrasound-responsive antibacterial biomaterials and expands the application of semiconductor nanomaterials beyond traditional drug delivery. The findings may provide useful opinions for the researchers in biomaterials, nanomedicine, and regenerative medicine seeking multifunctional platforms for infection treatment.